Picomets:黑色素瘤前哨淋巴结活检中单个或少数细胞转移的评估
该研究回顾了15年间752例在原发性黑色素瘤切除时接受淋巴结取样的患者,将单个淋巴结内1-4个Melan-A或Sox-10染色阳性的非典型细胞定义为「picomets」。作者认为将picomets归为N0可能低估其负性预后意义,需更大样本验证。
要点
- 单个淋巴结内1-4个Melan-A或Sox-10阳性非典型细胞定义为picomets,占4%。
- picomets患者总体预后优于历史分期匹配队列,但观察组中17%复发。
- 将picomets归为N0可能不反映其真实负性预后意义。
核心结论
- picomets患者预后优于历史分期匹配队列,但小部分出现复发,归为N0可能不反映真实负性预后意义。
研究设计与样本
- 回顾性研究,纳入15年间在本机构原发性黑色素瘤切除时接受淋巴结取样的752例患者。
主要发现
- 初始病理淋巴结分期不一,总体分期从IA到IIIC。
- 4例接受进一步治疗,均无复发;29例仅观察/监测中5例复发(17%)。
关键数值与推荐
- picomets定义为1个淋巴结内1至4个Melan-A或Sox-10染色阳性的非典型细胞。
临床怎么用
- 对符合picomets标准的患者应认识到其并非完全惰性,观察/监测期间存在复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lymph node involvement is a significant prognostic factor for melanoma. Both number of positive nodes and disease burden within a lymph node affects survival. However, the significance of few tumor cells within a single node and subsequent optimal management remains without consensus. We investigated the implications of minimal nodal disease on clinical outcomes. METHODS: We reviewed 752 patients who underwent lymph node sampling at time of primary melanoma resection at our institution over 15 years. We deemed patients who had 1 node with 1 to 4 atypical cells staining positive for either Melan-A or Sox-10 as having "picomets." We examined the initial clinicopathological features, subsequent management, and outcomes. RESULTS: Thirty-three patients (4%) met criteria for having picomets. The most common number of positively staining atypical cells was 1 (n = 13). Nodal staging at initial pathology review varied, and overall stage ranged from IA to IIIC. Four patients underwent further therapy, none of whom had recurrent disease. Of the 29 patients undergoing observation/surveillance only, 5 had disease recurrence (17%). CONCLUSION: Although patients with picomets had better outcomes than historical stage matched cohorts, a small subset had recurrent disease. Staging patients with picomets as "N0" may not reflect the true negative prognostic significance of picomets. A larger population of patients meeting picomets criteria is needed to draw further conclusions.
引用
- Jackson K, Ruffolo L, Kozakiewicz L, et al. Picomets: Assessing single and few cell metastases in melanoma sentinel lymph node biopsies. Surgery. 2021. PMID: 33902927. doi:10.1016/j.surg.2021.03.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。